MedTrace Logo

Evaluation of Salt Status in Patients With Cystic Fibrosis

NCT04556162 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 222

Last updated 2022-12-01

No results posted yet for this study

Summary

The results of the annual check-up will be collected to evaluate the best urinary marker for fractional sodium excretion and salt status will be correlated to clinical outcome measures.

Conditions

Interventions

DIAGNOSTIC_TEST

fractional sodium excretion

fractional sodium excretion will be compared to urinary sodium/creatinin, sodium/potassium ratio's and sodium concentration.

OTHER

risk subgroups

subgroup analysis will be performed to identify the patient groups at risk for sodium depletion

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Stephanie Van Biervliet, MD, PhD · Gent University hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2021-11-21
Completion
2021-11-21

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04556162 on ClinicalTrials.gov